{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:10:06Z","timestamp":1794568206736,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["19032"],"award-info":[{"award-number":["19032"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["U01DA021525"],"award-info":[{"award-number":["U01DA021525"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["U01DA038886"],"award-info":[{"award-number":["U01DA038886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>When the novel coronavirus pandemic emerged in March 2020, many settings across Canada and the USA were already contending with an existing crisis of drug overdoses due to the toxic unregulated drug supply. In response, the Canadian province of British Columbia (BC) released innovative risk mitigation prescribing (RMP) guidelines for medical professionals to prescribe pharmaceutical alternatives to unregulated drugs in an effort to support the self-isolation of people who use unregulated drugs (PWUD) in preventing both SARS-CoV-2 virus infection and overdoses. We sought to assess the level of awareness of RMP and identify factors associated with this awareness among PWUD in Vancouver, BC.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Cross-sectional data were derived from participants enrolled in three community-recruited prospective cohort studies of PWUD in Vancouver, interviewed between July and November 2020. Multivariable logistic regression analysis was used to identify factors associated with awareness of RMP.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 633 participants, 302 (47.7%) had heard of RMP. Of those 302 participants, 199 (65.9%) had never tried to access RMP services, ten (3.3%) made an unsuccessful attempt to access RMP, and 93 (30.8%) received RMP. In the multivariable analysis, participants who had awareness of RMP guidelines were more likely to self-identify as white (adjusted odds ratio [AOR]\u2009=\u20091.47; 95% confidence interval [CI]: 1.01, 2.13), to have completed secondary school education or higher (AOR\u2009=\u20091.67; 95% CI: 1.16, 2.39), to have used drugs at a supervised consumption or overdose prevention site in the past six months (AOR\u2009=\u20091.66; 95% CI: 1.10, 2.52), and to have received opioid agonist therapy as treatment for opioid use disorder in the past six months (AOR\u2009=\u20091.51; 95% CI: 1.02, 2.24).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>At least four months after the release of the guidelines, RMP was known to less than half of our study participants, warranting urgent educational efforts for PWUD, particularly among racialized groups and those who were not accessing other harm reduction services. Furthermore, the majority of participants who were aware of RMP guidelines had never tried to access the service, suggesting the need to improve perceived accessibility and knowledge of eligibility criteria.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-022-00632-6","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T11:03:04Z","timestamp":1653476584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada"],"prefix":"10.1186","volume":"19","author":[{"given":"Mana","family":"Moshkforoush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kora","family":"DeBeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupinder","family":"Brar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Fairbairn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-J.","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Buxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanis","family":"Oldenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kali","family":"Sedgemore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanna","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"632_CR1","doi-asserted-by":"crossref","unstructured":"Bowery NG. Fentanyl. In: Enna SJ, Bylund DB, editors. xPharm: the comprehensive pharmacology reference. New York: Elsevier; 2007 p. 1\u20135. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780080552323617453","DOI":"10.1016\/B978-008055232-3.61745-3"},{"key":"632_CR2","unstructured":"Fentanyl. United states drug enforcement administration. 2022 [cited 2022 Apr 11]. Available from: https:\/\/www.dea.gov\/factsheets\/fentanyl"},{"key":"632_CR3","unstructured":"World Drug Report Booklet 1. United Nations: office on drugs and crime. 2021 [cited 2022 Apr 11]. Available from: \/\/www.unodc.org\/unodc\/en\/data-and-analysis\/wdr-2021_booklet-1.html"},{"key":"632_CR4","unstructured":"Opioid- and Stimulant-related Harms in Canada. Government of Canada. 2022 [cited 2022 Apr 11]. Available from: https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/"},{"key":"632_CR5","unstructured":"Provincial Health Officer Declares Public Health Emergency. BC Gov News. 2016 [cited 2022 Apr 11]. Available from: https:\/\/news.gov.bc.ca\/releases\/2016HLTH0026-000568"},{"key":"632_CR6","unstructured":"BC Coroners Service. Statistical Reports on Deaths in British Columbia. Province of British Columbia. Province of British Columbia; 2022 [cited 2022 Apr 11]. Available from: https:\/\/www2.gov.bc.ca\/gov\/content\/life-events\/death\/coroners-service\/statistical-reports"},{"key":"632_CR7","unstructured":"B.C. Experiences record loss of life due to drug toxicity. BC Gov News. 2021 [cited 2022 Apr 11]. Available from: https:\/\/news.gov.bc.ca\/releases\/2021PSSG0099-002356"},{"issue":"1","key":"632_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.7326\/M20-1210","volume":"173","author":"WC Becker","year":"2020","unstructured":"Becker WC, Fiellin DA. When epidemics collide: coronavirus disease 2019 (COVID-19) and the opioid crisis. Ann Intern Med. 2020;173(1):59\u201360.","journal-title":"Ann Intern Med"},{"issue":"6","key":"632_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/add.15080","volume":"115","author":"J Marsden","year":"2020","unstructured":"Marsden J, Darke S, Hall W, Hickman M, Holmes J, Humphreys K, et al. Mitigating and learning from the impact of COVID-19 infection on addictive disorders. Addict Abingdon Engl. 2020;115(6):1007\u201310.","journal-title":"Addict Abingdon Engl"},{"issue":"212","key":"632_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108047","volume":"1","author":"AK Slaunwhite","year":"2020","unstructured":"Slaunwhite AK, Gan WQ, Xavier C, Zhao B, Buxton JA, Desai R. Overdose and risk factors for coronavirus disease 2019. Drug Alcohol Depend. 2020;1(212): 108047.","journal-title":"Drug Alcohol Depend"},{"key":"632_CR11","unstructured":"Changes Related to COVID-19 in the Illegal Drug Supply and Access to Services, and Resulting Health Harms (CCENDU Alert). Canadian Centre on Substance Use and Addiction. 2020[cited 2022 Apr 11]. Available from: https:\/\/www.ccsa.ca\/changes-related-covid-19-illegal-drug-supply-and-access-services-and-resulting-health-harms"},{"key":"632_CR12","unstructured":"World Drug Report Booklet 5. United nations: office on drugs and crime. 2021[cited 2022 Apr 11]. Available from: \/\/www.unodc.org\/unodc\/en\/data-and-analysis\/wdr-2021_booklet-5.html"},{"key":"632_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103237","volume":"93","author":"F Ali","year":"2021","unstructured":"Ali F, Russell C, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: a national qualitative assessment in Canada. Int J Drug Policy. 2021;93: 103237.","journal-title":"Int J Drug Policy"},{"key":"632_CR14","unstructured":"COVID-19. BCCSU. 2022 [cited 2022 Apr 11]. Available from: https:\/\/www.bccsu.ca\/covid-19\/"},{"key":"632_CR15","unstructured":"Woo A. B.C.\u2019s move to a \u2018safe supply\u2019 for drug users has a bumpy rollout. The Globe and Mail [Internet]. 2020 [cited 2022 Apr 11]; Available from: https:\/\/www.theglobeandmail.com\/canada\/british-columbia\/article-bcs-move-to-a-safe-supply-for-drug-users-has-a-bumpy-rollout\/"},{"key":"632_CR16","unstructured":"Harm Reduction Reports. BC centre for disease control. 2022 [cited 2022 Apr 11]. Available from: http:\/\/www.bccdc.ca\/health-professionals\/data-reports\/harm-reduction-reports#Substance--Use--&--Overdose"},{"issue":"3","key":"632_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11524-012-9771-x","volume":"90","author":"IA Linden","year":"2013","unstructured":"Linden IA, Mar MY, Werker GR, Jang K, Krausz M. Research on a vulnerable neighborhood-the vancouver downtown eastside from 2001 to 2011. J Urban Health Bull N Y Acad Med. 2013;90(3):559\u201373.","journal-title":"J Urban Health Bull N Y Acad Med"},{"issue":"3","key":"632_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1465-3362.2009.00145.x","volume":"29","author":"D Werb","year":"2010","unstructured":"Werb D, Debeck K, Kerr T, Li K, Montaner J, Wood E. Modelling crack cocaine use trends over 10 years in a Canadian setting. Drug Alcohol Rev. 2010;29(3):271\u20137.","journal-title":"Drug Alcohol Rev"},{"issue":"2","key":"632_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.drugpo.2005.12.007","volume":"17","author":"E Wood","year":"2006","unstructured":"Wood E, Kerr T. What do you do when you hit rock bottom? Responding to drugs in the city of Vancouver. Int J Drug Policy. 2006;17(2):55\u201360.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"632_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2307\/3341647","volume":"25","author":"A Kazempiur","year":"2000","unstructured":"Kazempiur A, Halli SS. Neighbourhood poverty in Canadian cities. Can J Sociol Cah Can Sociol. 2000;25(3):369\u201381.","journal-title":"Can J Sociol Cah Can Sociol"},{"issue":"6","key":"632_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.280.6.547","volume":"280","author":"SA Strathdee","year":"1998","unstructured":"Strathdee SA, Palepu A, Cornelisse PG, Yip B, O\u2019Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280(6):547\u20139.","journal-title":"JAMA"},{"issue":"3","key":"632_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1477-7517-3-18","volume":"24","author":"E Wood","year":"2006","unstructured":"Wood E, Stoltz J-A, Montaner JSG, Kerr T. Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study. Harm Reduct J. 2006;24(3):18.","journal-title":"Harm Reduct J"},{"issue":"338","key":"632_CR23","doi-asserted-by":"publisher","first-page":"b1649","DOI":"10.1136\/bmj.b1649","volume":"30","author":"E Wood","year":"2009","unstructured":"Wood E, Kerr T, Marshall BDL, Li K, Zhang R, Hogg RS, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;30(338):b1649.","journal-title":"BMJ"},{"issue":"3","key":"632_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","volume":"20","author":"T Rhodes","year":"2009","unstructured":"Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20(3):193\u2013201.","journal-title":"Int J Drug Policy"},{"key":"632_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-7138-7","volume-title":"An Introduction to statistical learning: with applications in R","author":"G James","year":"2013","unstructured":"James G, Witten D, Hastie T, Tibshirani R. Linear regression. In: James G, Witten D, Hastie T, Tibshirani R, editors. An Introduction to statistical learning: with applications in R. New York: Springer; 2013."},{"key":"632_CR26","unstructured":"SAS: Analytics, Artificial Intelligence and Data Management. SAS; 2022 [cited 2022 Apr 11]. Available from: https:\/\/www.sas.com\/en_us\/home.html"},{"issue":"225","key":"632_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.socscimed.2019.02.014","volume":"1982","author":"MC Kennedy","year":"2019","unstructured":"Kennedy MC, Boyd J, Mayer S, Collins A, Kerr T, McNeil R. Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver. Can Soc Sci Med. 2019;1982(225):60\u20138.","journal-title":"Can Soc Sci Med"},{"issue":"5","key":"632_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229208","volume":"15","author":"B Pauly","year":"2020","unstructured":"Pauly B, Wallace B, Pagan F, Phillips J, Wilson M, Hobbs H, et al. Impact of overdose prevention sites during a public health emergency in Victoria, Canada. PLoS ONE. 2020;15(5): e0229208.","journal-title":"PLoS ONE"},{"issue":"4","key":"632_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/0033354919857084","volume":"134","author":"S Moallef","year":"2019","unstructured":"Moallef S, Nosova E, Milloy MJ, DeBeck K, Fairbairn N, Wood E, et al. Knowledge of fentanyl and perceived risk of overdose among persons who use drugs in Vancouver. Can Public Health Rep. 2019;134(4):423\u201331.","journal-title":"Can Public Health Rep"},{"issue":"178","key":"632_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.socscimed.2017.01.053","volume":"1982","author":"A Goodman","year":"2017","unstructured":"Goodman A, Fleming K, Markwick N, Morrison T, Lagimodiere L, Kerr T, et al. \u201cThey treated me like crap and I know it was because I was native\u201d: the healthcare experiences of aboriginal peoples living in Vancouver\u2019s inner city. Soc Sci Med. 2017;1982(178):87\u201394.","journal-title":"Soc Sci Med"},{"issue":"11","key":"632_CR31","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s11606-009-1105-7","volume":"24","author":"LT Martin","year":"2009","unstructured":"Martin LT, Ruder T, Escarce JJ, Ghosh-Dastidar B, Sherman D, Elliott M, et al. Developing predictive models of health literacy. J Gen Intern Med. 2009;24(11):1211\u20136.","journal-title":"J Gen Intern Med"},{"key":"632_CR32","unstructured":"What is health literacy?. Centers for Disease Control and Prevention. 2022 [cited 2022 Apr 11]. Available from: https:\/\/www.cdc.gov\/healthliteracy\/learn\/index.html"},{"key":"632_CR33","unstructured":"Mental Health, B.C. Introduces new prescribed safer supply policy, a Canadian first. BC Gov News. 2021 [cited 2022 Apr 11]. Available from: https:\/\/news.gov.bc.ca\/releases\/2021MMHA0035-001375"},{"issue":"3","key":"632_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","volume":"51","author":"S Darke","year":"1998","unstructured":"Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253\u201363.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"632_CR35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.addbeh.2009.12.006","volume":"35","author":"LE Napper","year":"2010","unstructured":"Napper LE, Fisher DG, Johnson ME, Wood MM. The reliability and validity of drug users\u2019 self reports of amphetamine use among primarily heroin and cocaine users. Addict Behav. 2010;35(4):350\u20134.","journal-title":"Addict Behav"},{"key":"632_CR36","doi-asserted-by":"crossref","unstructured":"Needle R, Fisher DG, Weatherby N, Chitwood D, Brown B, Cesari H, et al. Reliability of self-reported HIV risk behaviors of drug users. - PsycNET [Internet]. 1995 [cited 2021 Oct 7]. Available from: https:\/\/psycnet.apa.org\/doiLanding?doi=10.1037%2F0893-164X.9.4.242","DOI":"10.1037\/0893-164X.9.4.242"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00632-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-022-00632-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00632-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T11:10:08Z","timestamp":1653477008000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-022-00632-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["632"],"URL":"https:\/\/doi.org\/10.1186\/s12954-022-00632-6","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"1 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All three studies (VIDUS, ACCESS, ARYS) have received ethics approval from the University of British Columbia\/Providence Health Care Research Ethics Board. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MJM\u2019s institution has received an unstructured gift from NG Biomed, Ltd., to support his research. MJM is the Canopy Growth professor of cannabis science at the University of British Columbia, a position created by unstructured gifts to the university from Canopy Growth, a licensed producer of cannabis, and the Government of British Columbia\u2019s Ministry of Mental Health and Addictions. The funder that supports MJM did not have any role in study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication. All authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}